CD28 and acute lymphoblastic leukemia: Using a synthetic aAPC that enables the precise delivery of anti-CD3/anti-CD28 stimulation via a physiological fluid bilayer, we generated a library of CAR-T cell products from healthy or patient (i.e., ALL or CLL) blood samples.